A PROSPECTIVE TRIAL OF TACROLIMUS (FK 506) IN CLINICAL HEART TRANSPLANTATION: INTERMEDIATE-TERM RESULTS

Between January 1, 1989, and December 31, 1994, we have treated 122 primary heart recipients with FK 506 (group I) and 121 with cyclosporine (group II). Fifty patients in the cyclosporine (CyA) group received no lympholytic induction (CyA alone) and 71 others received lympholytic induction with eith...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Pham, Si M., Kormos, Robert L., Hattler, Brack G., Kawai, Akihiko, Tsamandas, Athanassios C., Demetris, Anthony J., Murali, Srinivas, Fricker, Frederick J., Chang, Huang C., Jain, Ashosk B., Starzl, Thomas E., Hardesty, Robert L., Griffith, Bartley P.
Формат: Artigo
Язык:Inglês
Опубликовано: 1996
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3022508/
https://ncbi.nlm.nih.gov/pubmed/8614136
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы